Elicio Therapeutics, Inc. — Director's Dealing 2021

Sep 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Angion Biomedica Corp. (ANGN)
CIK: 0001601485
Period of Report: 2021-08-31

Reporting Person: EISA-ABC LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-31	Common Stock	J	913659	$0.00	Disposed	2740978	Direct

Footnotes

F1: EISA-ABC LLC distributed these shares to its then member, Elisha Goldberg, which represented his pro rata ownership interest in the shares held by EISA-ABC LLC, for no consideration.